Company Profiles

driven by the PitchBook Platform

Ario Pharma

Description

Developer of drug development platform designed to offer drugs for the treatment of respiratory indications The company's drug development platform offers new approaches to treat respiratory disease as well as helps in preventing cough in patients with chronic obstructive pulmonary disease (COPD), enabling healthcare professionals treat asthma and other inflammatory diseases.

2010

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$4.22M

Latest Deal Amount

$13.5M

Total Amount Raised

Description

Developer of drug development platform designed to offer drugs for the treatment of respiratory indications The company's drug development platform offers new approaches to treat respiratory disease as well as helps in preventing cough in patients with chronic obstructive pulmonary disease (COPD), enabling healthcare professionals treat asthma and other inflammatory diseases.

Website:

www.ariopharma.com

Formerly Known As

Provesica

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Drug Discovery

Primary Office

Saint John's Innovation Centre Cowley Road Cambridge CB4 0WSEngland +44 (0)12 2349 3922
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Ario Pharma's full profile, request a free trial.

Ario Pharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Ario Pharma Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Ario Pharma Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Forbion Capital PartnersVenture CapitalMinority000 0000000 0000
New Science VenturesVenture CapitalMinority000 0000000 0000
Seroba Life SciencesVenture CapitalMinority000 0000000 0000
Forbion Capital Partners Venture Capital
New Science Ventures Venture Capital
Seroba Life Sciences Venture Capital

Ario Pharma Executive Team (6)

NameTitleBoard
Seat
Contact
Info
John Ford Ph.DCo-Founder, Board Member & Chief Executive Officer
Edward StevensChief Scientific Officer
Dave Madge Ph.DVice President, Chemistry
Timothy Brears Ph.DManaging Director
Nick TaitDirector, Finance & Company Secretary
John Ford Ph.D Co-Founder, Board Member & Chief Executive Officer
Edward Stevens Chief Scientific Officer
Dave Madge Ph.D Vice President, Chemistry
Timothy Brears Ph.D Managing Director
Nick Tait Director, Finance & Company Secretary

Ario Pharma Board Members (8)

NameRepresentingRoleSinceContact
Info
Alan O'Connell Ph.DSeroba Life SciencesPartner000 0000
Geert-Jan Mulder MDForbion Capital PartnersCo-Founding Partner & General Partner000 0000
John Ford Ph.DArio PharmaCo-Founder, Board Member & Chief Executive Officer000 0000
Keith McCullagh Ph.DSelfChairman000 0000
Sander SlootwegForbion Capital PartnersCo-Founder & Managing Partner000 0000
Alan O'Connell Ph.D Partner Seroba Life Sciences
Geert-Jan Mulder MD Co-Founding Partner & General Partner Forbion Capital Partners
John Ford Ph.D Co-Founder, Board Member & Chief Executive Officer Ario Pharma
Keith McCullagh Ph.D Chairman Self
Sander Slootweg Co-Founder & Managing Partner Forbion Capital Partners
Request full access to PitchBook